Literature DB >> 21793104

Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2.

Bertrand Isidor1, Martine Le Merrer, G Ulrich Exner, Olivier Pichon, Gaelle Thierry, Anne Guiochon-Mantel, Albert David, Valérie Cormier-Daire, Cédric Le Caignec.   

Abstract

Serpentine fibula-polycystic kidney syndrome (SFPKS) is a rare disorder characterized by the association of craniofacial anomalies, radiological findings (wormian bones, elongated and bowed fibulae), polycystic kidneys, and normal intelligence. SFPKS shares many similarities with Hajdu-Cheney syndrome (HCS). We and others recently showed that truncating mutations in the last exon of NOTCH2 cause HCS. Here, we identify by Sanger sequencing two different heterozygous truncating mutations in the last exon of NOTCH2 in two unrelated patients with SFPKS. In one family, we show that the mutation occurred de novo. These findings demonstrate that SFPKS and HCS are both conditions caused by NOTCH2 mutations.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21793104     DOI: 10.1002/humu.21563

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

Review 1.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

Review 2.  Notch signaling in human development and disease.

Authors:  Andrea L Penton; Laura D Leonard; Nancy B Spinner
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

Review 3.  Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.

Authors:  Ernesto Canalis; Stefano Zanotti
Journal:  Curr Osteoporos Rep       Date:  2016-08       Impact factor: 5.096

Review 4.  Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.

Authors:  Ernesto Canalis
Journal:  Metabolism       Date:  2017-08-24       Impact factor: 8.694

5.  NOTCH2 mutations in Alagille syndrome.

Authors:  Binita Maya Kamath; Robert C Bauer; Kathleen M Loomes; Grace Chao; Jennifer Gerfen; Anne Hutchinson; Winita Hardikar; Gideon Hirschfield; Paloma Jara; Ian D Krantz; Pablo Lapunzina; Laura Leonard; Simon Ling; Vicky Lee Ng; Phuc Le Hoang; David A Piccoli; Nancy Bettina Spinner
Journal:  J Med Genet       Date:  2011-12-29       Impact factor: 6.318

6.  Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.

Authors:  Giovanni Adami; Maurizio Rossini; Davide Gatti; Giovanni Orsolini; Luca Idolazzi; Ombretta Viapiana; Aldo Scarpa; Ernesto Canalis
Journal:  Bone       Date:  2016-08-31       Impact factor: 4.398

7.  Improving the rigor of mutation reports: biologic parentage and de novo mutations.

Authors:  Leslie Biesecker
Journal:  Hum Mutat       Date:  2012-07-02       Impact factor: 4.878

Review 8.  From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease.

Authors:  Djalila Mekahli; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2013-01-24       Impact factor: 3.714

Review 9.  Notch signaling in skeletal health and disease.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2013-05-08       Impact factor: 6.664

Review 10.  Renal involvement and the role of Notch signalling in Alagille syndrome.

Authors:  Binita M Kamath; Nancy B Spinner; Norman D Rosenblum
Journal:  Nat Rev Nephrol       Date:  2013-06-11       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.